P.S. Free 2026 Salesforce ALS-Con-201 dumps are available on Google Drive shared by PDFVCE: https://drive.google.com/open?id=1XXb6nCwUrkEwJUdv84-u2EjzwSPlVxqi
The Salesforce ALS-Con-201 desktop-based practice exam is compatible with Windows-based computers and only requires an internet connection for the first-time license validation. The web-based Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) practice test is accessible on any browser without needing to install any separate software. Finally, the Salesforce Certified Agentforce Life Sciences Consultant (ALS-Con-201) dumps pdf is easily portable and can be used on smart devices or printed out.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Compliance and Security | 20% | - Implement data security for HIPAA compliance - Configure audit trails and tracking for FDA requirements - Set up data partitioning for multi-tenant pharmaceutical environments - Apply Field Audit Trail for regulated data |
| Topic 2: Discovery and Requirements Gathering | 20% | - Identify stakeholder requirements for Life Sciences implementations - Map business processes to Salesforce Agentforce capabilities - Document functional and technical requirements - Assess data quality and integration needs |
| Topic 3: Life Sciences Industry Overview and Salesforce Agentforce for Life Sciences | 15% | - Understand Life Sciences industry processes (pharmaceutical, biotech, medical device) - Describe how Agentforce applies to Life Sciences use cases - Explain key regulatory compliance requirements (FDA, GxP, HIPAA) |
| Topic 4: Testing, Deployment, and Enablement | 20% | - Create documentation for regulated environments - Plan and execute testing strategies for Life Sciences solutions - Develop training materials for Life Sciences users - Establish support processes for post-production compliance - Deploy Agentforce solutions following validation requirements |
| Topic 5: Solution Design and Configuration | 25% | - Implement Agentforce AI agents for clinical trial support - Design Agentforce solutions for Life Sciences scenarios - Configure Salesforce Health Cloud for Life Sciences - Build automation flows for compliance workflows - Design integration with external Life Sciences systems |
>> ALS-Con-201 Intereactive Testing Engine <<
The language of our ALS-Con-201 qualification test guide is simple. The learners may come from many social positions and their abilities to master our ALS-Con-201 test materials are varied. Based on this consideration we apply the most simple and easy-to-be-understood language to help the learners no matter he or she is the students or the in-service staff, the novice or the experienced employee which have worked for many years. ALS-Con-201 Certification guide use the simple language to explain the answers and detailed knowledge points to help pass the ALS-Con-201 exam.
NEW QUESTION # 36
Choose 1 option.
Cumulus Pharma implemented a custom predictive model outside of Salesforce to determine the optimal product message for Healthcare Providers (HCPs). The company wants to display these recommendations to its field sales teams within Salesforce.
Which object should an Agentforce Life Sciences Consultant load the external scores and rankings into to use the Next Best Message feature?
Answer: C
Explanation:
The correct answer is A because Next Best Message uses product-message scoring data at the territory-account-product-message level. Salesforce's Life Sciences Cloud Developer Guide states that Next Best Message provides tailored and relevant messages for each product associated with an account. Salesforce also documents the related scoring object and describes the calculation agent used to calculate the territory account product message score based on various metrics.
The scenario says Cumulus Pharma already has a custom predictive model outside Salesforce. The goal is not to build the model inside Salesforce, but to surface the model's results to reps through the standard Next Best Message capability. Therefore, the external scores and rankings should be loaded into the object that stores ranked product-message recommendations for accounts in territories: Territory Account Product Message Score.
Option B, Visit Recommendation, is not the best answer because the requirement is specifically about product messages for HCPs, not general recommendations tied to a visit. Option C, Score Explainability Info, may support interpretation or explanation of scoring, but it is not the primary object used to load the external product-message score and ranking. To use Next Best Message with external model outputs, the consultant should load the results into Territory Account Product Message Score.
=========
NEW QUESTION # 37
Choose 1 option.
An Agentforce Life Sciences Consultant is setting up sample limits for a controlled substance. Legal requires that, if a field sales rep attempts to disburse more than the allowed quantity, the system must strictly prevent the transaction. The rep should receive a message and be unable to submit the visit until the quantity is corrected.
How should the consultant configure the Limit Enforcement Type on the Sample Limit Template?
Answer: B
NEW QUESTION # 38
Choose 1 option.
Cumulus Pharma uses Agentforce Account Summary to provide the latest and most relevant account information before each Healthcare Provider (HCP) interaction. The company is onboarding a new persona for its Key Account Managers (KAMs). Provider account summaries generated for this new persona need information from two additional custom objects that store insights and market intelligence.
Which configuration ensures the new information is used only while generating the provider summary for this new persona?
Answer: C
Explanation:
Option A is correct because Account Summarization uses cross-object graphs to determine which related objects and relationships are included in generated summaries. Salesforce Life Sciences Account Summarization setup resources reference creating a cross-object graph for Account Summarization and assigning cross-object graphs to an org or profile. This supports persona-specific summary behavior because a graph can be configured with the additional custom objects and then assigned specifically to the KAM profile.
The requirement says the new information must be used only for the new KAM persona. That means the consultant should avoid changing the default or shared provider summary mapping used by other personas. By creating a separate cross-object graph from the template, adding the two custom insight and market-intelligence objects, and assigning that graph only to the KAM profile, the consultant isolates the new summary structure to the intended users.
Option B is not the best answer because globally updating Provider Summary Objects mapping could affect more than the KAM persona if the mapping is shared. Option C is also not the best answer because the key Account Summarization configuration pattern documented by Salesforce is graph creation and graph assignment to an org or profile. Therefore, the correct configuration is to create a new cross-object graph and assign it to the KAM profile.
=========
NEW QUESTION # 39
Choose 1 option.
Cumulus Pharma is launching a new "Immunology Monthly" newsletter for its "Immunexis" product. The Agentforce Life Sciences Consultant should configure the Consent Management module so that field sales reps can capture opt-ins for this specific newsletter.
Which record should the consultant create to link the "Immunology Monthly" Communication Subscription to the "Immunexis" product record?
Answer: C
Explanation:
Data Use Purpose is the correct answer. In Salesforce Life Sciences Cloud Consent Management, a Communication Subscription represents a specific subscription, such as a newsletter, and the consent model must also connect that subscription to the business purpose and relevant Life Sciences product. Salesforce's Life Sciences Help documentation specifically describes creating a Data Use Purpose record to associate a Life Sciences Marketable Product with a Communication Subscription. That directly matches the scenario: "Immunology Monthly" is the Communication Subscription, and "Immunexis" is the product record that must be linked for consent capture.
Engagement Channel Type is not correct because it represents the channel through which the HCP can be contacted, such as email, SMS, or other communication methods. It defines the communication channel, not the relationship between a subscription and a marketable product. Communication Subscription Consent is also not correct because it represents an individual customer's or HCP's consent preference for a subscription. In other words, that record is created or updated when the HCP opts in or opts out; it is not the setup record used to link the newsletter subscription to the product. Salesforce's Life Sciences standard object documentation also describes Communication Subscription Consent as representing a customer's consent to a communication subscription, reinforcing that it stores the HCP's consent outcome rather than the product-subscription configuration.
=========
NEW QUESTION # 40
Choose 1 option.
Cumulus Pharma requires that once a field sales rep finalizes and submits a visit report, it must become immutable and no further edits should be allowed.
Which configuration ensures this behavior?
Answer: B
Explanation:
The correct answer is C because the requirement is to lock a submitted visit report so it can no longer be edited. Salesforce Life Sciences Visit Management supports compliant planning, execution, and reporting for provider visits, and Salesforce Help directs administrators to use the Visit Management Admin Console to configure what fields users can see and how users can interact with and manage visit records.
A submitted visit report often represents a compliance-sensitive record, especially in life sciences, where visit details, sampling activity, consent capture, and inquiry handling may need to remain auditable after submission. Enabling VisitLockHandler enforces the locking behavior, while leaving Unlock submitted visit unchecked prevents the record from being reopened or edited after final submission. This configuration best matches the requirement that the submitted visit report become immutable.
Option A is incorrect because VisitAutoSaveHandler relates to saving visit data, and checking "Allow edits after submission" would contradict the stated requirement. The business specifically wants no further edits after submission. Option B is also incorrect because disabling a permissions handler and setting the status to Closed does not directly enforce immutable submitted-visit behavior. Status alone is not the same as a record lock. Therefore, the consultant should enable VisitLockHandler and ensure submitted visits remain locked by unchecking Unlock submitted visit in the Admin Console.
=========
NEW QUESTION # 41
......
It is not hard to know that ALS-Con-201 torrent prep is compiled by hundreds of industry experts based on the syllabus and development trends of industries that contain all the key points that may be involved in the examination. Therefore, with ALS-Con-201 exam questions, you no longer need to purchase any other review materials, and you also don’t need to spend a lot of money on tutoring classes. At the same time, ALS-Con-201 Test Guide will provide you with very flexible learning time in order to help you pass the exam.
ALS-Con-201 Latest Dumps: https://www.pdfvce.com/Salesforce/ALS-Con-201-exam-pdf-dumps.html
What's more, part of that PDFVCE ALS-Con-201 dumps now are free: https://drive.google.com/open?id=1XXb6nCwUrkEwJUdv84-u2EjzwSPlVxqi